Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion type Assertion NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_head.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion description "[We investigated dopaminergic inhibition of CD4+CD25(high) regulatory T lymphocytes (Treg) in relapsing-remitting multiple sclerosis (MS) patients treated with interferon (IFN)-?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_provenance.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion evidence source_evidence_literature NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_provenance.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion SIO_000772 22472872 NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_provenance.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion wasDerivedFrom befree-20150227 NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_provenance.
- NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_assertion wasGeneratedBy ECO_0000203 NP515917.RAzhcp14CyCXXmMkv3BZ6q41bWFjtcaI-hJv-RK3KIU3s130_provenance.